NUTX

SEC source: 0001486189-23-000036 · primary_doc.xml · nonDerivative · entry 1

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,678

SEC source: 0001486189-23-000024 · primary_doc.xml · nonDerivative · entry 4

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (5)

Disclosed balance after: 269,322,776

F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.27 to $0.30, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (4) to this Form 4.

SEC source: 0001486189-23-000024 · primary_doc.xml · nonDerivative · entry 3

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (5)

Disclosed balance after: 269,170,450

F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.30 to $0.33, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (3) to this Form 4.

F5 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 267,322,776 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 2,000,000 of the securities of the registrant reported herein.

SEC source: 0001486189-23-000024 · primary_doc.xml · nonDerivative · entry 2

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (5)

Disclosed balance after: 268,864,503

F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.29 to $0.33, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (2) to this Form 4.

F5 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 267,322,776 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 2,000,000 of the securities of the registrant reported herein.

SEC source: 0001486189-23-000024 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (5)

Disclosed balance after: 268,521,759

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.28 to $0.29, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

F5 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 267,322,776 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 2,000,000 of the securities of the registrant reported herein.

SEC source: 0001486189-23-000007 · primary_doc.xml · nonDerivative · entry 1

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,505

SEC source: 0001486189-23-000005 · primary_doc.xml · nonDerivative · entry 1

Creem Mitchell · CIK 0001572821 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See note(2)

Disclosed balance after: 81,746

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.4257 to $0.4301 inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

F2 · ownership.direct: Mitchell Creem, a Director of the registrant is a co-trustee of the Creem Family Trust, the direct owner of 81,746 of the securities of the registrant reported herein.

SEC source: 0001486189-23-000004 · primary_doc.xml · nonDerivative · entry 1

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,502

SEC source: 0001486189-23-000003 · primary_doc.xml · nonDerivative · entry 1

Reed Michael Lee · CIK 0001922252 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See note(2)

Disclosed balance after: 10,000

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.4252 to $0.4264 inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

F2 · ownership.direct: Michael L. Reed, a Director of the registrant is the sole trustee of Michael L Reed Trust IRA, the direct owner of 10,000 of the securities of the registrant reported herein.

SEC source: 0001486189-23-000006 · primary_doc.xml · nonDerivative · entry 1

Grenas Cheryl Yvonne · CIK 0001920511 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See note(1)

Disclosed balance after: 10,000

F1 · ownership.direct: Cheryl Grenas, a Director of the registrant is the indirect beneficial owner of 10,000 of the securities of the registrant reported herein of which Xavier Grenas, spouse of Cheryl Grenas is the direct owner.

SEC source: 0001486189-23-000002 · primary_doc.xml · nonDerivative · entry 4

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (5)

Disclosed balance after: 268,322,776

F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.48 to $0.50, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (4) to this Form 4

F5 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 267,322,776 of the securities of the registrant reported herein and and is the sole trustee of Vo Family Limited Partnership, the direct owner of 1,000,000 of the securities of the registrant reported herein.

SEC source: 0001486189-23-000002 · primary_doc.xml · nonDerivative · entry 3

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (5)

Disclosed balance after: 268,304,748

F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.48 to $0.49, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (3) to this Form 4.

F5 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 267,322,776 of the securities of the registrant reported herein and and is the sole trustee of Vo Family Limited Partnership, the direct owner of 1,000,000 of the securities of the registrant reported herein.

SEC source: 0001486189-23-000002 · primary_doc.xml · nonDerivative · entry 2

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (5)

Disclosed balance after: 267,822,660

F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.50 to $0.62, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (2) to this Form 4.

F5 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 267,322,776 of the securities of the registrant reported herein and and is the sole trustee of Vo Family Limited Partnership, the direct owner of 1,000,000 of the securities of the registrant reported herein.

SEC source: 0001486189-23-000001 · primary_doc.xml · nonDerivative · entry 1

Waters John J · CIK 0001296807 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,262

SEC source: 0001486189-23-000002 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (5)

Disclosed balance after: 267,437,660

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.46 to $0.51, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

F5 · ownership.direct: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 267,322,776 of the securities of the registrant reported herein and and is the sole trustee of Vo Family Limited Partnership, the direct owner of 1,000,000 of the securities of the registrant reported herein.

SEC source: 0001062993-23-010664 · form4.xml · derivative · entry 6

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F3 · derivative.exercise_date: Represents 20,000 RSUs issued and vested on April 1, 2023.

F3 · derivative.expiration_date: Represents 20,000 RSUs issued and vested on April 1, 2023.

F1 · derivative.underlying_shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001062993-23-010664 · form4.xml · derivative · entry 5

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F3 · derivative.exercise_date: Represents 20,000 RSUs issued and vested on April 1, 2023.

F3 · derivative.expiration_date: Represents 20,000 RSUs issued and vested on April 1, 2023.

F1 · derivative.underlying_shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001062993-23-010664 · form4.xml · derivative · entry 4

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,010

Underlying: Common Stock · 49,505 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.

F1 · derivative.underlying_shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001062993-23-010664 · form4.xml · derivative · entry 3

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,515

Underlying: Common Stock · 148,515 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.

F1 · derivative.underlying_shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001062993-23-010664 · form4.xml · nonDerivative · entry 2

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,505

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001062993-23-010664 · form4.xml · nonDerivative · entry 1

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,505

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001062993-23-010662 · form4.xml · derivative · entry 3

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,003

Underlying: Common Stock · 16,502 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.

F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001062993-23-010662 · form4.xml · derivative · entry 2

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,505

Underlying: Common Stock · 49,505 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.

F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.

F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001062993-23-010662 · form4.xml · nonDerivative · entry 1

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,502

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

SEC source: 0001062993-22-023884 · form4.xml · nonDerivative · entry 2

Premier Macy Management Holdings, LLC · CIK 0001920021 · 10% owner

Young Matthew Stephen · CIK 0001920043 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,964,832

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by Premier Macy Management Holdings, LLC ("Premier").

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.12, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.

F3 · ownership.direct: Premier is the direct beneficial owner of the securities reported herein. Matthew Stephen Young is the managing member of Premier and a director of Nutex Health, Inc. Mr. Young disclaims beneficial ownership of any securities that exceed his pecuniary interest in Premier.

SEC source: 0001062993-22-023884 · form4.xml · nonDerivative · entry 1

Premier Macy Management Holdings, LLC · CIK 0001920021 · 10% owner

Young Matthew Stephen · CIK 0001920043 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,008,712

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by Premier Macy Management Holdings, LLC ("Premier").

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.445, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.

F3 · ownership.direct: Premier is the direct beneficial owner of the securities reported herein. Matthew Stephen Young is the managing member of Premier and a director of Nutex Health, Inc. Mr. Young disclaims beneficial ownership of any securities that exceed his pecuniary interest in Premier.

SEC source: 0001486189-22-000019 · primary_doc.xml · nonDerivative · entry 2

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 248,975

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.30, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

SEC source: 0001486189-22-000018 · primary_doc.xml · nonDerivative · entry 2

Bowen Michael · CIK 0001856020 · Retired CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 437,105

SEC source: 0001486189-22-000019 · primary_doc.xml · nonDerivative · entry 1

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,975

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.41, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

SEC source: 0001486189-22-000018 · primary_doc.xml · nonDerivative · entry 1

Bowen Michael · CIK 0001856020 · Retired CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 446,622

SEC source: 0001486189-22-000017 · primary_doc.xml · nonDerivative · entry 2

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 448,975

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.80 to $2.98, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

SEC source: 0001486189-22-000017 · primary_doc.xml · nonDerivative · entry 1

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 598,975

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.99 to $3.20, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

SEC source: 0001486189-22-000016 · primary_doc.xml · nonDerivative · entry 3

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 698,975

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.7500 to $2.8271, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

SEC source: 0001486189-22-000016 · primary_doc.xml · nonDerivative · entry 2

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 798,975

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4009 to $2.5031, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

SEC source: 0001486189-22-000016 · primary_doc.xml · nonDerivative · entry 1

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 978,975

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.5445 to $2.5840, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

SEC source: 0001062993-22-017072 · form4.xml · derivative · entry 2

Waters John J · CIK 0001296807 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 64,516 shares

Expires 2022-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.

F1 · derivative.exercise_price: Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.

F1 · derivative.expiration_date: Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.

SEC source: 0001062993-22-017072 · form4.xml · nonDerivative · entry 1

Waters John J · CIK 0001296807 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001486189-22-000015 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,706,960

SEC source: 0001486189-22-000014 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,706,960

SEC source: 0001486189-22-000010 · primary_doc.xml · nonDerivative · entry 1

Reed Michael Lee · CIK 0001922252 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,208

F1 · shares: Vesting 1/12 on date of grant and 1/12 on the last day of each month beginning May 2022 through March 2023.

SEC source: 0001486189-22-000009 · primary_doc.xml · nonDerivative · entry 1

Grenas Cheryl Yvonne · CIK 0001920511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,280

F1 · shares: Vesting 1/12 on date of grant and 1/12 on the last day of each month beginning May 2022 through March 2023.

SEC source: 0001486189-22-000012 · primary_doc.xml · nonDerivative · entry 1

Creem Mitchell · CIK 0001572821 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,208

F1 · shares: Vesting 1/12 on date of grant and 1/12 on the last day of each month beginning May 2022 through March 2023.

SEC source: 0001486189-22-000011 · primary_doc.xml · nonDerivative · entry 1

Waters John J · CIK 0001296807 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,851

F1 · kind: Vesting 1/12 on date of grant and 1/12 on the last day of each month beginning May 2022 through March 2023.

SEC source: 0001486189-22-000022 · primary_doc.xml · nonDerivative · entry 2

Reed Michael Lee · CIK 0001922252 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · date: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock.

F1 · kind: The Amendment reports the rescission of the Restricted Stock Awards initially granted on May 9, 2022, as reported in the original Form 4.

F2 · price: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock.

SEC source: 0001486189-22-000022 · primary_doc.xml · nonDerivative · entry 1

Reed Michael Lee · CIK 0001922252 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,208

SEC source: 0001486189-22-000023 · primary_doc.xml · nonDerivative · entry 2

Grenas Cheryl Yvonne · CIK 0001920511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · date: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock.

F1 · kind: The Amendment reports the rescission of the Restricted Stock Awards initially granted on May 9, 2022, as reported in the original Form 4.

F2 · price: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock.

SEC source: 0001486189-22-000023 · primary_doc.xml · nonDerivative · entry 1

Grenas Cheryl Yvonne · CIK 0001920511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,280

SEC source: 0001486189-22-000021 · primary_doc.xml · nonDerivative · entry 2

Creem Mitchell · CIK 0001572821 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · date: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock.

F1 · kind: The Amendment reports the rescission of the Restricted Stock Awards initially granted on May 9, 2022, as reported in the original Form 4.

F2 · price: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock.

SEC source: 0001486189-22-000021 · primary_doc.xml · nonDerivative · entry 1

Creem Mitchell · CIK 0001572821 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,208

SEC source: 0001486189-22-000020 · primary_doc.xml · nonDerivative · entry 2

Waters John J · CIK 0001296807 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · date: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock.

F1 · kind: The Amendment reports the rescission of the Restricted Stock Awards initially granted on May 9, 2022, as reported in the original Form 4.

F2 · price: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock.